results, page-4

I think people were hoping they could get out at the release - ie those that bought >$1.60 saw it fall and then recover. Some fatigue selling imo.

I for one think it is amateurish they can't get the major annoucements out before market open. Not releasing any guidance whatsoever would also have led to a few sellers I believe.

Throw in CCP's results and people were hoping for me.

The very low multiple, less than 10!, is real however.

The market is not seeing that H2 was a NPAT results of around $12m before one-offs. So there is any chance of NPAT growth of around 20%+ to say something like $22m (which is less than H216's annualised result).

I got in at prices closer to $2 and I am confident that patience will see this achieved within 3-5months.

I think there's real potential for Nov guidance to be towards $23-25m if this was the case then the forward PE is 7!